Beveridge Claire A, Farha Natalie, Hermanns Christina, Maruggi Chiara, Falloon Katherine, Thanawala Shivani, Harnegie Mary Pat, Brown J Mark, Ivanov Andrei I, Dellon Evan S, Falk Gary W, Ma Christopher, Gonsalves Nirmala, Lembo Anthony, Muir Amanda B, Gabbard Scott, Furuta Glenn T, Rieder Florian
Department of Gastroenterology, Hepatology & Nutrition, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Aliment Pharmacol Ther. 2025 Aug;62(3):277-299. doi: 10.1111/apt.70187. Epub 2025 Jun 19.
BACKGROUND: Fibrostenosis is a serious complication of eosinophilic oesophagitis, but there is a lack of consensus regarding its definition and assessment. This poses a barrier in clinical care and research. AIM: To perform a systematic review to examine existing definitions and diagnostic methods of detection regarding fibrostenosis in eosinophilic oesophagitis. METHODS: We searched MEDLINE, Cochrane Library, EMBASE, Scopus, and Web of Science and included studies of paediatric and adult eosinophilic oesophagitis patients with fibrostenosis based on endoscopy, imaging, histopathology, functional studies, and biomarkers. We excluded studies with <10 patients. We chose fibrostenosis as the umbrella term, encompassing all definitions. RESULTS: We identified 230 studies. The four categories of fibrostenosis definitions were: (1) structural findings (stricture, rings, and/or narrowings) (n=204, 88.7%), (2) histology (n=85, 37.0%), (3) functional (functional lumen imaging probe) (n=15, 6.5%), and (4) biomarkers (n=7, 3.0%). Multiple definitions were used in 78 studies. Methods used to detect structural fibrostenosis included Eosinophilic Oesophagitis Endoscopic Reference Score fibrostenotic components, luminal diameter (endoscopy or imaging), need for dilation, and endoscopist or radiologist global impression. Methods used to detect histologic fibrostenosis included Eosinophilic Oesophagitis Histologic Scoring System lamina propria fibrosis, pathologist global impression, and basal zone hyperplasia. Methods used to detect functional fibrostenosis included distensibility and compliance. CONCLUSIONS: Significant variability exists in definitions and diagnostic methods of detection regarding fibrostenosis in eosinophilic oesophagitis. Lack of agreement hampers progress in further investigating this complication. Development of consensus criteria is necessary to provide clarity for clinical care and research.
背景:纤维狭窄是嗜酸性粒细胞性食管炎的一种严重并发症,但关于其定义和评估缺乏共识。这在临床护理和研究中构成了障碍。 目的:进行一项系统评价,以研究嗜酸性粒细胞性食管炎中纤维狭窄的现有定义和检测诊断方法。 方法:我们检索了MEDLINE、Cochrane图书馆、EMBASE、Scopus和科学网,并纳入了基于内镜检查、影像学、组织病理学、功能研究和生物标志物的儿童和成人嗜酸性粒细胞性食管炎合并纤维狭窄患者的研究。我们排除了患者少于10例的研究。我们选择纤维狭窄作为总括性术语,涵盖所有定义。 结果:我们识别出230项研究。纤维狭窄的四类定义为:(1)结构表现(狭窄、环和/或狭窄处)(n = 204,88.7%),(2)组织学(n = 85,37.0%),(3)功能(功能腔成像探头)(n = 15,6.5%),以及(4)生物标志物(n = 7,3.0%)。78项研究使用了多种定义。用于检测结构性纤维狭窄的方法包括嗜酸性粒细胞性食管炎内镜参考评分的纤维狭窄成分、管腔直径(内镜检查或影像学)、扩张需求以及内镜医师或放射科医师的整体印象。用于检测组织学纤维狭窄的方法包括嗜酸性粒细胞性食管炎组织学评分系统的固有层纤维化、病理学家的整体印象以及基底区增生。用于检测功能性纤维狭窄的方法包括扩张性和顺应性。 结论:嗜酸性粒细胞性食管炎中纤维狭窄的定义和检测诊断方法存在显著差异。缺乏一致性阻碍了对这一并发症进一步研究的进展。制定共识标准对于为临床护理和研究提供清晰指导很有必要。
Aliment Pharmacol Ther. 2025-8
Cochrane Database Syst Rev. 2017-9-21
Cochrane Database Syst Rev. 2014-11-24
Health Technol Assess. 2001
Cochrane Database Syst Rev. 2022-7-12
Health Technol Assess. 2024-10
Aliment Pharmacol Ther. 2011-2-14
Cochrane Database Syst Rev. 2015-6-23
Dis Esophagus. 2025-1-7
Gastro Hep Adv. 2024-1-24
J Allergy Clin Immunol Pract. 2024-9